Veeflox

Veeflox is an oral fluoroquinolone antibiotic developed and marketed by Vintage Labs. Its active ingredient is ofloxacin, a small molecule that inhibits bacterial DNA gyrase and topoisomerase IV. These enzymes are critical for bacterial DNA replication, transcription, repair, and recombination. By targeting these enzymes, Veeflox effectively halts bacterial growth and division. It is approved for the treatment of various bacterial infections in adults, including respiratory tract infections (chronic bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, sexually transmitted infections like gonorrhea, and infections of the ear, nose, and throat.

Brand names

VeefloxVeeflox 200Veeflox200Veeflox-200

Other names

ofloxacin